Below are the top biotechnology stocks on the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at PDL BioPharma PDLI is 90.90%. PDL BioPharma's ROA for the same period is 51.00%.
The trailing-twelve-month operating margin at Enzon Pharmaceuticals ENZN is 82.70%. Enzon Pharma's EPS for the same period is $0.59.
The trailing-twelve-month operating margin at Pain Therapeutics PTIE is 68.30%. Pain Therapeutics' revenue for the same period is $37.20 million.
The trailing-twelve-month operating margin at Anika Therapeutics ANIK is 57.60%. Anika Therapeutics' PEG ratio is 0.59.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in